Healthcare -
Biotechnology - NASDAQ - US
$ 1.745
0.867 %
$ 265 M
Market Cap
-10.91
P/E
Price Target
Average
301.15%
Revenue Forecast
Estimate
26.13%
EBIT
Estimate
--30.66%
Net Income
Estimate
34.81%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Heron Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for HRTX of $7 , with forecasts ranging from
a
low of
$5 to a high of $9 .
HRTX Lowest Price Target
Wall Street Target
5 USD
186.53%
HRTX Average Price Target
Wall Street Target
7 USD
301.15%
HRTX Highest Price Target
Wall Street Target
9 USD
415.76%
REVENUE FORECAST
Revenue Forecast Chart HRTX
EBIT FORECAST
EBIT Forecast Chart HRTX
NET INCOME FORECAST
Net Income Chart HRTX